COVID-19: viral infection, endotheliopathy and the immuno-inflammatory response… is it time to consider a standard (non-immunized) plasma therapy approach to maintain homeostasis?

Frédérique Dufour-Gaume; Emilie Javelle; Anne Sailliol; Andre P. Cap; Nicolas J. Prat

doi:10.1016/j.tracli.2022.04.002

COVID-19: viral infection, endotheliopathy and the immuno-inflammatory response… is it time to consider a standard (non-immunized) plasma therapy approach to maintain homeostasis?

Frédérique Dufour-Gaume^*, Emilie Javelle, Anne Sailliol, Andre P. Cap, Nicolas J. Prat

^*Corresponding author for this work

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	191-194
Number of pages	4
Journal	Transfusion Clinique et Biologique
Volume	29
Issue number	3
DOIs	https://doi.org/10.1016/j.tracli.2022.04.002
State	Published - Aug 2022
Externally published	Yes

Access to Document

10.1016/j.tracli.2022.04.002

Cite this

@article{6aaa1ef0e8ab47dfbc643bcc70f85e99,

title = "COVID-19: viral infection, endotheliopathy and the immuno-inflammatory response… is it time to consider a standard (non-immunized) plasma therapy approach to maintain homeostasis?",

author = "Fr{\'e}d{\'e}rique Dufour-Gaume and Emilie Javelle and Anne Sailliol and Cap, {Andre P.} and Prat, {Nicolas J.}",

year = "2022",

month = aug,

doi = "10.1016/j.tracli.2022.04.002",

language = "English",

volume = "29",

pages = "191--194",

journal = "Transfusion Clinique et Biologique",

issn = "1246-7820",

number = "3",

}

COVID-19: viral infection, endotheliopathy and the immuno-inflammatory response… is it time to consider a standard (non-immunized) plasma therapy approach to maintain homeostasis? / Dufour-Gaume, Frédérique; Javelle, Emilie; Sailliol, Anne et al.
In: Transfusion Clinique et Biologique, Vol. 29, No. 3, 08.2022, p. 191-194.

Research output: Contribution to journal › Editorial

TY - JOUR

T1 - COVID-19

T2 - viral infection, endotheliopathy and the immuno-inflammatory response… is it time to consider a standard (non-immunized) plasma therapy approach to maintain homeostasis?

AU - Dufour-Gaume, Frédérique

AU - Javelle, Emilie

AU - Sailliol, Anne

AU - Cap, Andre P.

AU - Prat, Nicolas J.

PY - 2022/8

Y1 - 2022/8

UR - http://www.scopus.com/inward/record.url?scp=85130970175&partnerID=8YFLogxK

U2 - 10.1016/j.tracli.2022.04.002

DO - 10.1016/j.tracli.2022.04.002

M3 - Editorial

C2 - 35644840

AN - SCOPUS:85130970175

SN - 1246-7820

VL - 29

SP - 191

EP - 194

JO - Transfusion Clinique et Biologique

JF - Transfusion Clinique et Biologique

IS - 3

ER -

COVID-19: viral infection, endotheliopathy and the immuno-inflammatory response… is it time to consider a standard (non-immunized) plasma therapy approach to maintain homeostasis?

Access to Document

Fingerprint

Cite this